Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Brain Tumors and Neurologic Cancers

The focus of the Vanderbilt Brain Tumor Center is to provide comprehensive compassionate care to patients with brain tumors. We have assembled a dedicated team of clinicians and scientists who are committed to finding a cure for brain cancer. We are passionate in this pursuit.

Clinical Trials for Neurologic / Brain Cancers

6 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Diagnostic

VICCNEU1268

05/01/2012

Early Detection of Glioma Treatment Response Using MRI-Based Biomarkers

Treatment

ECOGRADN107C

03/20/2015

Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

Treatment

VICCNEU1404

07/30/2014

A Randomized Phase 3 Open Label Study of Nivolumab versus Bevacizumab and a Safety Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Adult Subjects with Recurrent Glioblastoma (GBM)

Treatment

VICCMD1403

06/02/2014

An Open Label, Phase II Study of Neratinib in Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification

Treatment

VICCMEL1398

05/23/2014

BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation- Positive Melanoma that has Metastasized to the Brain

Treatment

VICCRAD1060

02/15/2011

A Phase I Trial of Sorafenib and Stereotactic Radiosurgery for Patients with 1-4 Brain Metastases